[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi
2016, Cilt 30, Sayı 2, Sayfa(lar) 075-078
[ Özet ] [ PDF ] [ Benzer Makaleler ] [ Editöre E-Posta ]
Laparotomi Uygulanan Ratlarda Oksidatif Stres Üzerine Fluniksin Meglumin, Diklofenak Sodyum, Metamizol Sodyum ve Karprofenin Etkileri
Nuh KILIÇ1, L. Didem KOZACI2
1Adnan Menderes Üniversitesi, Veteriner Fakültesi, Cerrahi Anabilim Dalı, Aydın, TÜRKİYE
2Yıldırım Beyazıt Üniversitesi, Tıp Fakültesi, Tıbbi Biyokimya Anabilim Dalı, Ankara, TÜRKİYE
Anahtar Kelimeler: Oksidatif stres, Laparatomi, NSAID, rat
Özet
Bu çalışmada laparatomi uygulanan ratlarda bazı nonsteroid antiinflamatuar grubu ilaçların oksidatif stres üzerine etkilerinin belirlenmesi amaçlandı. Ratlar (n=50) 5 eşit gruba ayrıldı. Kontrol grubuna (Grup I) serum fizyolojik verilirken, diğer Grup II-IV' e sırasıyla metamizol 50 mg/kg (II), flunixin meglumin 2.5 mg/kg (III), carprofen 2.5 mg/kg (IV) ve diklofenak sodium 2.5 mg/kg (V) intraperitoneal 5 gün süreyle enjekte edildi. Postoperatif 6. günde kan örnekleri alınarak serum malondialdehit (MDA) ve nitrik oksit (NO) düzeyleri ve eritrosit glutatyon (GSH) ve katalaz seviyeleri belirlendi. NSAID grubu ilaçlar MDA, NO ve GSH seviyesinde bir azalmaya neden olurken, katalaz seviyesinde artışa yol açtı. Sonuç olarak NSAID grubu ilaçların anti-inflamatuar etkilerine ek olarak değişik yollardan oksidatif stresi azaltabilirler.
  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Giriş
    Peritoneal adhesions are among the most common complications of abdominal laparotomy, with high risk of morbidity and mortality1. There have been several attempts to prevent or reduce peritoneal adhesion formation which is a consequence of an inflammatory process. Numerous defects, namely as insufficient antioxidant status, increased inflammatory mediators and ischemia may participate in pathophysiology of intra-abdominal fibrin deposition and adhesions2,3.

    In response to injury, cells attracted to the site (neutrophils, macrophages, etc), as wells local ones, produce mediators such as cytokines, adhesion molecules, free oxygen radicals, nitric oxide (NO), and arachidonic acid metabolites to initiate healing. Elevated levels of pro-inflammatory mediators activate transcription factors such as NFκB which act as signalling mediators for a variety of signal transduction pathways and gene expression, and stimulate production of NO and reactive oxygen species (ROS)4. Formation of elevated levels of ROS such as hydroxyl radicals, superoxides, and peroxides has been reported in various inflammatory conditions. Activated free oxygen radicals shown to be responsible for cell-membrane peroxidation which leads to arachidonic acid and free fatty acids formation, a process which then can induce generation of more ROS5. Therefore, although inflammation is a necessary step in wound healing the persistence of inflammation as a result of prolonged exposure to stimulus can lead to tissue damage and fibrosis6. Thus, targeting inflammation at an early stage at cellular level may allow specific attenuation of operatively induced adhesion formation via inhibiting uncontrolled production of NO, ROS, lipid oxidation, cellular damage and finally adhesion formation2,3.

    Nonsteroidal anti-inflammatory drugs (NSAID) are among the most widely used pharmaceuticals in humans and animals for their anti-inflammatory effects. The anti-inflammatory effects of NSAIDs are thought to be mainly on the cyclooxygenases (COX) (7). COX enzymes (COX-1 and COX-2) are the first in a cascade of enzymes that convert arachidonic acid into prostaglandins (PG) and thromboxane (Tx), which are involved in inflammation, cancer, and embryonic development8. NSAIDs such as aspirin, indomethacin, naproxen, diclofenac, metamizole, and flunixin inhibit both COX-1 and COX-2 non-selectively and are widely used for the treatment of various inflammatory and non-inflammatory conditions such as arthritis, cardiovascular diseases, and the management of postsurgical and post-traumatic pain in clinical and veterinary medicine9-11. COX inhibitors such as resveratrol have been reported to have antioxidant features13. On the other hand, antioxidant agents such as thioctic acid have been reported to be effective in acute inflammation via reduction of NO, malondialdehyde (MDA), COX-2 mRNA and induction of glutathione (GSH), IL-10 mRNA14.

    In this study, we asked the question whether NSAID treatment following laparotomic surgery would also reduce the oxidative stress in rats and wanted to evaluate the efficacy of various NSAIDs for this matter.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Materyal ve Metot
    The study was conducted with 6-months-old, out-brade female Wistar rats (n=50) with a mean weight of 200-250 g. Rats were obtained from our animal facilities and treated in accordance with the guidelines for Animal Research from the National Institutes of Health as approved by the local committee on animal research. The animals were housed in stainless steel cages under controlled temperature and humidity conditions with 12/12-hour light/dark cycles. All rats were maintained on a standard laboratory diet with tap water ad libitum throughout the experiment. Laparotomy was performed under sterile conditions after intraperitoneal injection of ketamine (50 mg/kg) and xylazine HCL (10 mg/kg) as anesthetic agents. The rats were divided into five equal groups. The control group (Group I) received serum physiologic. We injected the drugs; metamizole (50 mg/kg), flunixin meglumine (2.5 mg/kg), carprofen (2.5 mg/kg), and diclofenac (2.5 mg/kg) intraperitoneally for 5 days to Groups II, III, IV and V, respectively. Each group also consisted of n=10 animals. On postoperative day 6, blood samples were obtained for biochemical analyses and animals were sacrificed by exsanguination.

    Measurement of Serum MDA Levels: MDA concentration in serum samples was measured spectrophotometrically in terms of thiobarbituric acid reactive substances (TBARS). Serum samples were mixed with 20% trichloroacetic acid and 0.67% thiobarbituric acid. The mixture was then boiled at 95°C for 30 min, immediately followed by cooling on ice. The reaction mixture was then vortexed, following the addition of n-butanol. All vials were then centrifuged at 3000 rpm for 10 min. The absorbance of the supernatant was then measured at 535 nm. The concentration of lipid peroxidation products was calculated as MDA concentration using the extinction coefficient for the MDA-thiobarbituric acid complex of 1.56x105/mol/cm

    Measurement of Nitric Oxide: Serum NO levels were determined indirectly by measuring the concentrations of nitrite (NO2 -) and nitrate (NO3-), as the indices of NO16. NO (nitrite+nitrate) levels were analyzed using a modification of cadmium-reduction method of Cortas and Wakid16. Samples were deproteinized and then centrifuged at 10.000 g for 20 min at 4°C. Cadmium (Cd) granules were activated using CuSO4 solution in glycine–NaOH buffer. Then, deproteinized samples and standards were added. The nitrate, reduced to nitrite with cadmium granules and the nitrite concentration were quantified by a reaction of nitrite with a mixture of naphthethylenediamine and sulfanilamide, based on the Griess reaction, in which a chromophore with a strong absorbance at 540 nm is formed. The samples were analyzed using a microplate reader and quantified against nitrite standard curve and the results were expressed as μmol/L.

    Erythrocyte Lysate Preparation: Blood samples were collected in tubes containing EDTA, then centrifuged (3000 rpm 10 min at +4 °C) and plasma and buffy coat (leucocytes) were removed. The packed red cells were washed three times with 0.9% NaCl and hemolyzed with 4 volume of ice-cold deionized water to obtain stock hemolysate containing ∼5 g hemoglobin/100 ml. Hemoglobin concentration in each lysate was measured using Drabkin method17.

    Measurement of Erythrocyte GSH Levels: Erythrocyte GSH concentrations were measured according to the method of Tietze, using metaphosphoric acid for protein precipitation and 5-5’-dithio-bis-2-nitrobenzoic acid (DTNB) for colour development18. DTND is a disulfide compound, readily reduced by sulfhydryl compounds that form a coloured yellow anion. The optical density of this yellow substance is measured at 412 nm. GSH levels were expressed as µ,mol/ mg Hb.

    Measurement of Erythrocyte Catalase Enzyme Activity: Catalase level was measured in a fresh suspension of hemolysates. Dilution, 1:1000 of the concentrated hemolysate was prepared with phosphate buffer immediately before the assay. Catalase activity was determined by the spectrophotometric/enzymatic method of Aebi19. Buffer solution was prepared with potassium di-hydrogen phosphate and disodium hydrogen phosphate. The samples were diluted with buffer solution and the absorbance after addition of hydrogen peroxide buffer was recorded at 240 nm at the 15th second. The results were given as U/g Hb.

    Statistical Analysis: Statistical analysis was performed using SPSS for Windows version 10.0 program. All data were reported as mean values±standard deviations (SD). Comparisons between experimental and control groups were performed with Mann Whitney-U test. A value of P<0.05 was considered significant.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Bulgular
    Effects of NSAIDs on oxidative stress markers were summarized in Table 1. Regarding the antioxidant status, there was a decrease in plasma levels of both reduced GSH and MDA. Although this decrease was not statistically significant in any of the treatment groups, change in MDA levels was statistically significant in all but flunixin treated rats (Table 1). No statistical difference was observed in NO levels between any treatment groups compared to the controls although there was a slight decrease at NO levels in rats, treated with NSAIDs. Regarding catalase levels on the other hand, an increase was observed in all NSAID treated groups only being significant in metamisole group (P=0.037) compared to its control group.


    Büyütmek İçin Tıklayın
    Table 1: Effects of NSAIDs on oxidative stress markers in serum and erythrocyte lysates from rats subjected to laparotomy

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Tartışma
    Abdominal laparotomy induced peritoneal adhesions may even occur in the absence of infection20,21. In adhesion formation, an inflammatory reaction is the first step in the common pathway, whereas oxidative stress is the triggering and/or sustaining factor of inflammation14. Previous studies have shown that although ROS production was required for the performance of specific physiological functions, excessive ROS generation was harmful, and has been implicated in the pathogenesis of a number of diseases, including adhesion formation.

    There is a complex interaction between arachidonic acid metabolites and ROS. During the oxidation step of arachidonic acid by COX and lipoxygenase (LOX), ROS may be generated as a by product, whereas ROS itself was also reported to induce cell-membrane peroxidation which leads to arachidonic acid and free fatty acids formation5. In this study, we investigated the effects of NSAIDs with COX inhibitory effects, particularly metamisole, flunixin meglumine, carprofen and diclofenac on oxidative stress in rats subjected to laparotomy.

    MDA is a by-product of increased oxidative stress due to lipid peroxidation in several inflammatory conditions. Increased concentrations of MDA in tissues and blood reflect increase lipid peroxidation, making MDA a good marker of cell membrane injury. In our study, treatment of NSAID caused a decrease in serum MDA levels in Groups II-V, compared to the control group (Table 1). This decrease was statistically significant in all but flunixin-treated rats. Our results regarding the decreased MDA levels in sera of NSAID treated rats are in agreement with previous studies22.

    Another marker of oxidative stress is nitric oxide which is needed for vasodilatation and angiogenesis during the early phases of wound repair23. NO is also important in inflammation24. A recent study by El-Shitany et al.14 reported thioctic acid, an antioxidant agent and indomethacin to reduce inflammation and to decrease MDA and NO production in carrageenan-induced acute inflammation in rats. In our study, we also showed a decrease in NO levels in rats treated with NSAIDs. This decrease was statistically significant only in Group II compared to the controls (P=0.031).

    The balance between generation of free radicals and antioxidants is of critical importance for functional integrity of the cells as deficiency of antioxidants such as glutathione peroxidase and catalase along with excessive production of free radicals may lead to cellular destruction. Glutathione peroxidase catalyzes the reduction of hydrogen peroxide to water and oxygen, hence limits the formation of hydroxyl radical, the highly toxic reactive oxygen species whereas catalase is necessary for decomposition of hydrogen peroxide. In our study, an increase in catalase levels was observed in all NSAID treatment groups compared to controls but again, only in metamisole group (II) this increase was statistically significant (P=0.044). Similar results were reported by Sen et al.22 showing lornoxicam and nitroglycerin to cause an increase in catalase activity.

    GSH, a cofactor of glutathione peroxidase is another anti-oxidant that plays an important role in the cellular defence cascade against oxidative injury. The studies questioning the effects of NSAIDs on glutathione production are various and not conclusive. While several researchers describe depleted glutathione levels due to NSAID use, there also are studies reporting restoration of depleted GSH levels with NSAIDs14,25. In our study, all of the NSAIDs we used caused a decrease in erythrocyte reduced GSH levels compared to the controls. The decreases we observed were not significant in any of the NSAID treatment groups (Table 1). One explanation for this decrease may be a possible increase in utilization of glutathione by increased GPx levels in erythrocytes to counteract ROS as a consequence of NSAID treatment. To enlighten this hypothesis further studies are required. Our results regarding decreased GSH levels in NSAID treated rats are in disagreement with the results of Shitany et al.14 showing antioxidant agent thioctic acid and indomethasin restoring depleted GSH levels in acute inflammation and also with the results of Kirimlioglu et al.13 showing increased GSH levels in rats subjected to partial hepatectomy and treated with NSAID resveratrol. One explanation for these differences might be the choice of NSAIDs used in these studies and our study, as well as the doses and administration ways of the drugs26.

    In conclusion, one or more of the mechanisms mentioned above may be responsible for the oxidative stress and inflammation leading to peritoneal adhesion following laparatomic operations. Our data suggest that NSAIDs are likely to diminish the oxidative stress via different routes therefore combined or alternate regimes of these drugs to enhance their antioxidative effects and to prevent the unwanted side effects due to chronic use should be the choice of therapy. Further studies are required to reach an ultimate conclusion before fully understand their pathways of action. NSAIDs seem to decrease the traumatic effects of laparotomy.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Kaynaklar

    1) Menzies D, Ellis H. Intestinal obstruction from adhesions-how big is the problem? Ann R Coll Surg Engl 1990; 72: 60-63.

    2) Durmus AS, Yıldız H, Yaman I, et al. Efficacy of vitamin E and selenium for the prevention of intra-abdominal adhesions in rats: Uterine horn models. Clinics 2011; 66: 1247-1251.

    3) Durmus AS, Yıldız H, Yaman I, et al. The effects of heparin and pentoxifylline on prevention of intra-abdominal adhesions in rat uterine horn models: Histopathological and biochemical evaluations. Revue Med Vet, 2011; 162: 198-203.

    4) Munhoz CD, García-Bueno B, Madrigal JL, et al. Stress-induced neuroinflammation: Mechanisms and new pharmacological targets. J Med Biol Res 2008; 41: 1037-1046.

    5) Kim C, Kim JY, Kim JH. Cytosolic phospholipase A2, lipoxygenase metabolites, and reactive oxygen species. BMB Rep 2008; 41: 555-559.

    6) Germolec DR, Frawley RP, Evans E. Markers of inflammation. Methods Mol Biol 2010; 598: 53-73.

    7) Higgins GM, Anderson AR. Experimental pathology of the liver restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.

    8) Mihara M, Uchiyama M. Effects of antioxidants on the TBA reaction of various rat liver homogenates. Biochem Med 1983; 30: 131-134.

    9) Uzlu E, Citil M, Atakisi O, Yapar K, Erdogan HM. Effects of different nonsteroid antiinflammatory drugs on free triiodothyronin (fT(3)), free thyroxin (fT(4)) and thyroid stimulating hormone concentration in rabbits. Kafkas Univ Vet Fak Derg 2007; 13: 185-189.

    10) Erpek S, Kilic N, Kozacı LD, Dikicioğlu E, Kavak T. Effects of flunixin meglumine, diclofenac sodium and metamizol sodium on experimental wound healing in rats. Rev Med Ved 2006; 157: 185-192.

    11) Karabulut AB, Kirimlioglu V, Kirimlioglu H, et al. Protective effects of resveratrol on spleen and ileum in rats subjected to ischemia-reperfusion. Transplant Proc 2006; 38: 375.

    12) Carnovale CE, Scapini C, Alvarez ML, et al. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. J Hepatol 2000; 32: 798-804.

    13) Kirimlioglu V, Karakayali H, Turkoglu S, et al. Effect of resveratrol on oxidative stress enzymes in rats subjected to 70% partial hepatectomy. Transplantation Proceedings, 2008; 40: 293-296.

    14) El-Shitany NA, El-Masry SA, El-Ghareib MA, et al. Thioctic acid protects against carrageenan-induced acute inflammation in rats by reduction in oxidative stress, downregulation of COX-2 mRNA and enhancement of IL-10 mRNA. Fundam Clin Pharmacol 2010, 24: 91-99.

    15) Yoshioka T, Kawada K, Shimada T, et al. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372-376.

    16) Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.

    17) Drabkin DL. The crystallographic and optical properties of the Hb of man in comparison with those of other species. J Biol Chem 1946; 164: 703-723.

    18) Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.

    19) Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.

    20) Alpay Z, Ozgonenel MS, Savasan S, et al. Possible role of natural immune response against altered fibroblasts in the development of post-operative adhesions. Am J Reprod Immunol 2006; 55: 420-427.

    21) Roy S, Clark CJ, Mohebali K, et al. Reactive oxygen species and EGR-1 gene expression in surgical postoperative peritoneal adhesions. World J Surg 2004; 28: 316-320.

    22) Sen S, Doger FC, Sen S, et al. The protective effect of nitroglycerin on gastrointestinal and renal side effects of lornoxicam in rats. Eur J Pharmacol 2006; 541: 191-197.

    23) Blandizzi C, Fornai M, Colucci R, et al. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatorydrugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005; 11: 4052-4060.

    24) Shimizu M, Tatsuno M, Matsushita R, et al. Correlation between the physicochemical property of some nonsteroidal anti-inflammatory drugs and changes in adenosine triphosphate, glutathione and hemoglobin in rat erythrocytes biol. Pharm Bull 2003; 26: 1155-1165.

    25) Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001; 386: 302-308.

    26) Singh JP. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis. Curr Opin Investig Drug 2007; 8: 736-741.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • [ Başa Dön ] [ Özet ] [ PDF ] [ Benzer Makaleler ] [ Editöre E-Posta ]
    [ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]